[Viral hepatitis during pregnancy].
Viral hepatitis is one of the most common liver diseases appearing during pregnancy. Prevention against hepatotropic viruses is restricted due to lack of vaccines being effective in induction of efficient immunization in the majority of these microorganisms. In general, there is no possibility of active immunization against hepatotropic viruses except type A and B viral hepatitis. An issue of viral hepatitis in pregnancy as an aspect of potential risk factor connected with infection of pregnant women and a fetus has been described in this paper. Furthermore, the most important topics in the field of the epidemiology, prophylaxis and possible treatment options of viral hepatitis A, B, C, D, E and G have been discussed. The newest reports of pregnant women lamivudine therapy as a preventive treatment against vertical transmission during delivery have been reviewed. Rarly diagnosed viral hepatitis caused by herpes simplex virus, cytomegalovirus, Epstein-Barr virus and adenoviruses have been characterized as well.
Gutkowski
Krzysztof
K
Oddział Chorób Wewnetrznych, Szpitala Ministerstwa Spraw Wewnqtrznych i Administracji, Rzeszowie. kgutski@intertele.pl
Gutkowska
Dorota
D
Lepiech
Jacek
J
D000998:Antiviral Agents / Q000627:therapeutic use; D042241:Early Diagnosis; D005260:Female; D006506:Hepatitis A / Q000517:prevention & control; D006509:Hepatitis B / Q000517:prevention & control; D006526:Hepatitis C / Q000517:prevention & control; D003699:Hepatitis D / Q000517:prevention & control; D016751:Hepatitis E / Q000517:prevention & control; D006525:Hepatitis, Viral, Human / Q000517:prevention & control* / Q000628:therapy; D006801:Humans; D008429:Maternal Welfare; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control* / Q000628:therapy; D012307:Risk Factors; D014761:Viral Hepatitis Vaccines / Q000627:therapeutic use
D000998:Antiviral Agents; D014761:Viral Hepatitis Vaccines